Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11890778 | 0.88 | TSHR (0.50) | POLBKMT2AMEN1TSHRSMN1; SMN2 | |
| SCHEMBL11890787 | 0.84 | POLB (0.41) | POLBKMT2AMEN1TSHRSMN1; SMN2 | |
| SCHEMBL8219149 | 0.84 | POLB (0.43) | POLBKMT2AMEN1TSHRSMN1; SMN2 | |
| SCHEMBL18874629 | 0.82 | POLB (0.44) | POLBKMT2AMEN1TSHRSMN1; SMN2 | |
| SCHEMBL4193243 | 0.82 | CYP3A4 (0.34) | TSHRALDH1A1 | |
| SCHEMBL8059914 | 0.81 | POLB (0.45) | POLBKMT2AMEN1TSHRSMN1; SMN2 | |
| SCHEMBL10813947 | 0.81 | KMT2A (0.47) | POLBKMT2AMEN1TSHRSMN1; SMN2 | |
| SCHEMBL437536 | 0.81 | POLB (0.45) | POLBKMT2AMEN1TSHRSMN1; SMN2 | |
| SCHEMBL7999385 | 0.80 | KMT2A (0.47) | POLBKMT2AMEN1TSHRALDH1A1 | |
| SCHEMBL17387566 | 0.80 | POLB (0.52) | POLBKMT2AMEN1TSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1361246-B1 | ORGANIC POLYMER AND NOVEL POLYMERIZABLE COMPOUND | MITSUI CHEMICALS INC (JP) | 2009-02-18 | — | — | EP | disclosed |
| US-6797805-B2 | Organic polymers and novel polymerizable compounds | MITSUI CHEMICALS, INC. (JP) | 2004-09-28 | — | — | US | disclosed |
| EP-1361246-A1 | ORGANIC POLYMER AND NOVEL POLYMERIZABLE COMPOUND | Mitsui Chemicals, Inc. (JP) | 2003-11-12 | — | — | EP | disclosed |
| US-20030166808-A1 | Organic polymers and novel polymerizable compound | MITSUI CHEMICALS, INC. (JP) | 2003-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030166808-A1 | Organic polymers and novel polymerizable compound | PCNA, UTP18, ODC1 | POLB 188/4885KMT2A 2338/4885MEN1 3941/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.